| 11179359 |
Treatment of NAFLD and NASH |
Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Charles A. McWherter |
2021-11-23 |
| 10722483 |
Treatment of NAFLD and NASH |
Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Charles A. McWherter |
2020-07-28 |
| 10342770 |
Treatment of NAFLD and NASH |
Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Charles A. McWherter |
2019-07-09 |
| 10188620 |
Treatment for NAFLD and NASH |
Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Charles A. McWherter |
2019-01-29 |
| 10098843 |
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
Charles A. McWherter, David Karpf, Brian K. Roberts, Douglas Alan Lorenz, Rodney James Ketner |
2018-10-16 |
| 9962346 |
Treatment of NAFLD and NASH |
Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Charles A. McWherter |
2018-05-08 |
| 9616039 |
Treatment of NAFLD and NASH |
Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Charles A. McWherter |
2017-04-11 |
| 9381181 |
Treatment of NAFLD and NASH |
Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Charles A. McWherter |
2016-07-05 |
| 9241924 |
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
Charles A. McWherter, David Karpf, Brian K. Roberts, Douglas Alan Lorenz, Rodney James Ketner |
2016-01-26 |